• About
  • Advertise
  • Careers
  • Contact
  • Cookie Policy (EU)
Wednesday, May 31, 2023
  • Login
No Result
View All Result
NEWSLETTER
Tipperary Times - Tipperary News as it Happens
  • Local News
  • Community
  • Business
  • Farming
  • Politics
  • Education
  • Life Style
  • Jobs
  • Sport
  • Local News
  • Community
  • Business
  • Farming
  • Politics
  • Education
  • Life Style
  • Jobs
  • Sport
No Result
View All Result
Tipperary Times - Tipperary News as it Happens
No Result
View All Result
Home Business

Nutriband Inc. Announces the Appointment of Larry Dillaha, MD as Chief Medical Officer and to Advisory Board

by Paddy Ryan
August 2, 2018
in Business
0
Nutriband2 1

Nutriband2 1

0
SHARES
Share on FacebookShare on Twitter

ORLANDO, Fla., Aug. 2, 2018 /PRNewswire/ — Nutriband Inc. (OTCQB: NTRB) announced the appointment of Larry Dillaha, MD as chief medical officer and as a member of its Pharmaceutical Advisory Board.

Dr. Dillaha brings nearly 20 years of pharmaceutical industry experience to Nutriband. Prior to joining Nutriband, he was chief executive officer of Repros Therapeutics from February 2017 to February 2018. Prior to joining Repros, Dr. Dillaha was the chief executive officer of CavtheRx, an inception stage biotechnology company, from June 2016 to February 2017, and chief operating officer and chief medical officer of New Haven Pharmaceuticals, a specialty pharmaceutical company. He also served as chief medical officer of Insys Therapeutics, Sciele Pharma and as Medical Director of Sanofi-Sythelabo. Dr. Dillaha received an M.D. degree from the University of Tennessee, Memphis.

Gareth Sheridan, Nutriband’s chief executive officer, said, “Dr. Dillaha’s extensive experience includes substantial work in the therapeutic area of pain management, adding to the significant depth of the Nutriband scientific team as we work to develop and commercialize critical ADF transdermal products to this important area of pain therapy.”

—

Nutriband Inc.

Nutriband is a results driven, health and pharmaceutical company based in Orlando, Florida.  With the acquisition of 4P, Nutriband now has a pipeline of potential transdermal products in various stages of development. All Nutriband products are based around the science of transdermal/topical technologies.  Nutriband’s website is www.nutriband.com.

About Our Forward-Looking Statements

Certain statements contained in this press release, including, without limitation, statements containing the words “believes,” “anticipates,” “expects” and words of similar import, constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995.  Such forward-looking statements involve both known and unknown risks and uncertainties. Our actual results may differ materially from those anticipated in our forward-looking statements as a result of a number of factors, including our ability to develop and market new products; our ability to complete the necessary testing in order to obtain regulatory approval; the safety and efficacy of any products we develop, our ability to obtain necessary financial to complete the regulatory process and market any products that we develop, our ability to create, sustain, manage or forecast our growth; our ability to attract and retain key personnel; changes in our business strategy or development plans; competition; business disruptions; adverse publicity and international, national and local general economic and market conditions.  Except as required by applicable law, we undertake no obligation to revise or update any of our forward-looking statements in order to reflect any event or circumstance that may arise after the date hereof.  Information on our website or any other website does not constitute a part of this press release.

For more information, contact:

www.nutriband.com

SOURCE Nutriband Inc.

Next Post

Upperchurch Drombane GAA Clubnews - Weekly Club Notes – Aug 3rd 2018

© 2021 An AMV Publication - Agency Partner Trigger Media.

No Result
View All Result
  • Home
  • Community
  • Local News
  • Business
  • Tipperary Sport
  • Farming
  • Obituaries
  • Education
  • Entertainment
  • Health
  • Life Style
  • Opinion
  • Politics
  • Contact

© 2021 An AMV Publication - Agency Partner Trigger Media.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
Manage Cookie Consent
We use cookies to optimize our website and our service.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage vendors Read more about these purposes
Preferences
{title} {title} {title}